Sg Americas Securities, LLC Sqz Biotechnologies CO Transaction History

Sg Americas Securities, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$0.53 - $0.87 $14,534 - $23,858	27,423 Added 171.43%	43,420 $24,000
Q3 2022 Oct 31, 2022	BUY	$2.16 - $3.48 $432 - $696	200 Added 1.27%	15,997 $36,000
Q2 2022 Jul 29, 2022	SELL	$2.77 - $5.0 $12,597 - $22,740	-4,548 Reduced 22.35%	15,797 $50,000
Q1 2022 Apr 29, 2022	SELL	$4.01 - $10.42 $5,148 - $13,379	-1,284 Reduced 5.94%	20,345 $98,000
Q4 2021 Feb 07, 2022	SELL	$8.93 - $14.85 $142,049 - $236,218	-15,907 Reduced 42.38%	21,629 $193,000
Q3 2021 Nov 01, 2021	SELL	$11.46 - $15.77 $57,265 - $78,802	-4,997 Reduced 11.75%	37,536 $541,000
Q2 2021 Aug 12, 2021	BUY	$11.32 - $14.45 $23,522 - $30,027	2,078 Added 5.14%	42,533 $615,000
Q1 2021 May 13, 2021	BUY	$12.07 - $29.9 $306,746 - $759,878	25,414 Added 168.96%	40,455 $553,000
Q4 2020 Feb 04, 2021	BUY	$13.25 - $34.58 $199,293 - $520,117	15,041 New	15,041 $436,000

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.